SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
Tumormarkerek - Medicover
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-anal | CMAR
Diagnostics | Free Full-Text | The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy
Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
Tumormarker vizsgálatok az F MEDICAL Magánklinikán
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics
Tumor marker jajnika (CA 125, HE4, ROMA index) - kompletna analiza za samo 2760 rsd - HitDoktor.com grupna kupovina
Tumor marker levels and risk of ovarian malignancy algorithm (ROMA)... | Download Scientific Diagram
Mit jelent a HE4 érték a laborleletben? | Dr. Girhiny Tamás
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis. - Document - Gale Academic OneFile
JGO :: Journal of Gynecologic Oncology
Tumor marker jajnika (CA 125, HE4, ROMA index) - kompletna analiza u Poliklinici na Zvezdari!
Human Epididymis Protein 4 - an overview | ScienceDirect Topics
Tumormarker szűrővizsgálat Hölgyek részére - Dr. Binó Brúnó
Correlations between IOTA index, CA125, HE4, ROMA index | Download Scientific Diagram
ROMA (Risk of Ovarian Malignancy Algorithm) | PPT
ROMA Index Laboratory research Synevo
He4 and Risk for Ovarian Cancer Algorithm - Dr Lal PathLabs Blog
Comparison of the diagnostic accuracy of HE4 with CA125 and validation of the ROMA index in differentiating malignant and benign epithelial ovarian tumours amon
Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer | International Journal of Cancer
Table I from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
Malignancy Risk Assessment for Adnexal Ovarian Masses
The receiver operating characteristic of risk of ovarian malignancy... | Download Scientific Diagram
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article
![PDF] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ee64ab230d3264a10ced4c6827d39d8b87b0b704/3-Table2-1.png "PDF] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Semantic Scholar")
PDF] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Semantic Scholar
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
